No Data
No Data
Cocrystal Pharma Announces Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against The Emerging GII.17 Variants
Cocrystal Pharma Presents to Investment Community
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
Cocrystal Pharma Approves 2025 Equity Incentive Plan
COCRYSTAL PHARMA Earnings Preview: Recent $COCP Insider Trading, Hedge Fund Activity, and More
Cocrystal Pharma (COCP) Gets a Buy From Noble Financial
Eugh : @Jaguar8 I need your opinion on this please
$Apimeds Pharmaceuticals (APUS.US)$ IOP April 25
Eugh : I subscribed and I'm sweating like balls
Do most subscriptions play out good?
Jaguar8 OP Eugh : subscribed???
Jaguar8 OP Eugh : Net loss 1.42M, EPS -0.11, negative cash flow. No approved products. Only 2 Employees which is very concerning if this is a biotech company
Jaguar8 OP Eugh : i already gave you information
View more comments...